| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8790275 | Urologic Oncology: Seminars and Original Investigations | 2017 | 7 Pages |
Abstract
RT offers excellent CSS for men with stage I/II seminoma and an increased risk of SMN later in life. Future studies should better evaluate risk-stratification for stage IB patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Hiten D. M.D., M.P.H., Arnav M.P.H., Ridwan M.P.H., Gregory A. M.D., Zeyad R. M.D., Alice M.D., Mohamad E. M.D., Phillip M. M.D.,